Literature DB >> 18317236

The role of mannose-binding lectin in susceptibility to infection in preterm neonates.

Agnieszka B Dzwonek1, Olaf W Neth, Rodolphe Thiébaut, Ewa Gulczynska, Marcia Chilton, Thomas Hellwig, Mona Bajaj-Elliott, Jane Hawdon, Nigel J Klein.   

Abstract

Preterm neonates are susceptible to infection due to a combination of sub-optimal immunity and increased exposure to invasive organisms. Mannose-binding lectin (MBL) is a component of the innate immune system, which may be especially important in the neonatal setting. The objective of this study was to investigate the impact of MBL on susceptibility and severity of infection in preterm neonates during their first month of life. One hundred fifty eight preterm neonates were genotyped for MBL mutations by heteroduplex analyses. Consecutive serum MBL levels were measured by ELISA and clinical and laboratory data, including blood cultures, were collected for each baby. A third of the premature neonates had genetically determined MBL deficiency. In addition, MBL levels were also low in the first week of life and lower in neonates with a wild type genotype who were less than 28 wk gestation or a birth weight of less than 1000 g, thereby increasing the number of neonates with a low MBL level at birth. MBL deficiency was associated with an increased risk of sepsis (p < 0.01). This study indicates that MBL levels are low in neonates at birth and renders premature neonates to an increased risk of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317236     DOI: 10.1203/PDR.0b013e31816fdbff

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

Review 1.  Do multiple concurrent infections in African children cause irreversible immunological damage?

Authors:  Sarah J Glennie; Moffat Nyirenda; Neil A Williams; Robert S Heyderman
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 2.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

Review 3.  Role of innate immunity in neonatal infection.

Authors:  Alex G Cuenca; James L Wynn; Lyle L Moldawer; Ofer Levy
Journal:  Am J Perinatol       Date:  2013-01-07       Impact factor: 1.862

Review 4.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 5.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 6.  Association between innate immunity gene polymorphisms and neonatal sepsis development: a systematic review and meta-analysis.

Authors:  Tamara Sljivancanin Jakovljevic; Jelena Martic; Jelena Jacimovic; Nadja Nikolic; Jelena Milasin; Tanja Lazić Mitrović
Journal:  World J Pediatr       Date:  2022-06-06       Impact factor: 9.186

Review 7.  The developing human preterm neonatal immune system: a case for more research in this area.

Authors:  Ashish Arunkumar Sharma; Roger Jen; Alison Butler; Pascal M Lavoie
Journal:  Clin Immunol       Date:  2012-08-17       Impact factor: 3.969

Review 8.  Why are preterm newborns at increased risk of infection?

Authors:  Amélie Collins; Jörn-Hendrik Weitkamp; James L Wynn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-01-30       Impact factor: 5.747

Review 9.  Developmental biology of the innate immune response: implications for neonatal and infant vaccine development.

Authors:  Victoria Jane Philbin; Ofer Levy
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

Review 10.  Factors of the lectin pathway of complement activation and their clinical associations in neonates.

Authors:  Maciej Cedzynski; Anna St Swierzko; David C Kilpatrick
Journal:  J Biomed Biotechnol       Date:  2012-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.